Heart failure and diabetes mellitus are two of the greatest global health burdens and their prevalence is steadily increasing. At the same time, heart failure is becoming one of the most common causes of morbidity and mortality in western industrialized nations. Viewing heart failure and diabetes as closely linked entities raises the question of how early intervention can prevent patients’ prognosis from deteriorating.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Across All Types of Cancer
Four-Legged Medical Assistants – Therapy Dogs in Clinical Settings
- Obesity: More than half of those affected have fatty liver disease
From screening to multimodal intervention with GLP-1-RA or resmetirom
- Innovative Oral Treatment Options for Psoriasis: Icotrokinra and Zasocitinib
First-class immunomodulation combined with convenience—the data available so far is convincing
- Preclinical Study on a Special Ginkgo biloba Extract
What role do proanthocyanidins play?
- Myasthenia gravis: immunomodulatory therapies for long-term treatment
Expanded Possibilities Thanks to Innovative Classes of Active Ingredients
- Interstitial Lung Diseases
Update on Idiopathic Pulmonary Fibrosis
- Plastic surgery and reconstructive microsurgery for DFS
Functional limb preservation between infection control, vascular medicine and resurfacing
- Ischemic stroke: Are smaller or larger brain arteries affected?